# OnCo record giles-robinson (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/giles-robinson/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "giles-robinson" ;
  schema:name "Giles W. Robinson"@en ;
  schema:description "Memphis paediatric neuro-oncologist who led the study showing that the Hedgehog inhibitor vismodegib helps only adults and older children whose medulloblastoma belongs to the SHH subgroup, an early example of subgroup-directed brain tumour therapy."@en ;
  schema:url <https://onco.cc/people/giles-robinson/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  onco:tag "paediatric", "brain", "targeted-therapy", "trialist" ;
  schema:jobTitle "Paediatric neuro-oncologist, St. Jude Children's Research Hospital" ;
  schema:sameAs <https://orcid.org/0000-0001-7441-9486> ;
  onco:cancers <https://onco.cc/cancers/medulloblastoma-shh/>, <https://onco.cc/cancers/medulloblastoma/>, <https://onco.cc/cancers/childhood-cancers/> ;
  onco:institutions <https://onco.cc/institutions/st-jude/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-robinson-vismodegib-shh-medulloblastoma-jco-2015/> ;
  schema:affiliation <https://onco.cc/institutions/st-jude/> .